Steris PLC (STE)
213.06
+3.54
(+1.69%)
USD |
NYSE |
May 07, 16:00
213.06
0.00 (0.00%)
After-Hours: 17:12
Steris Cash from Financing (TTM): -133.36M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -133.36M |
September 30, 2023 | -55.78M |
June 30, 2023 | -570.94M |
March 31, 2023 | -498.72M |
December 31, 2022 | -581.38M |
September 30, 2022 | -650.24M |
June 30, 2022 | -844.39M |
March 31, 2022 | 115.83M |
December 31, 2021 | 293.52M |
September 30, 2021 | 1.125B |
June 30, 2021 | 1.298B |
March 31, 2021 | 345.62M |
December 31, 2020 | 433.26M |
September 30, 2020 | -298.94M |
June 30, 2020 | -289.54M |
March 31, 2020 | -163.15M |
December 31, 2019 | -264.86M |
September 30, 2019 | -218.46M |
June 30, 2019 | -263.18M |
March 31, 2019 | -294.79M |
December 31, 2018 | -344.18M |
September 30, 2018 | -376.70M |
June 30, 2018 | -373.14M |
March 31, 2018 | -356.18M |
December 31, 2017 | -254.33M |
Date | Value |
---|---|
September 30, 2017 | -224.83M |
June 30, 2017 | -246.34M |
March 31, 2017 | -267.10M |
December 31, 2016 | -301.42M |
September 30, 2016 | 219.78M |
June 30, 2016 | 467.05M |
March 31, 2016 | 560.29M |
December 31, 2015 | 644.79M |
September 30, 2015 | 140.54M |
June 30, 2015 | -38.48M |
March 31, 2015 | 69.75M |
December 31, 2014 | 86.97M |
September 30, 2014 | 69.39M |
June 30, 2014 | 89.71M |
March 31, 2014 | -54.21M |
December 31, 2013 | -94.90M |
September 30, 2013 | 24.57M |
June 30, 2013 | 275.80M |
March 31, 2013 | 254.25M |
December 31, 2012 | 278.91M |
September 30, 2012 | 184.80M |
June 30, 2012 | -83.10M |
March 31, 2012 | -88.07M |
December 31, 2011 | -97.64M |
September 30, 2011 | -78.62M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-844.39M
Minimum
Jun 2022
1.298B
Maximum
Jun 2021
-64.30M
Average
-218.46M
Median
Sep 2019
Cash from Financing (TTM) Benchmarks
Edwards Lifesciences Corp | -442.70M |
ResMed Inc | -914.60M |
Stryker Corp | -1.531B |
Align Technology Inc | -351.10M |
Nutriband Inc | 2.087M |